Bill Few Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$279K Buy
5,987
+18
+0.3% +$833 0.06% 194
2026
Q1
$293K Buy
5,969
+18
+0.3% +$837 0.07% 169
2025
Q4
$259K Buy
5,951
+15
+0.3% +$685 0.06% 178
2025
Q3
$267K Buy
5,936
+469
+9% +$20.6K 0.07% 166
2025
Q2
$237K Buy
5,467
+7
+0.1% +$312 0.07% 169
2025
Q1
$252K Buy
+5,460
New +$228K 0.09% 151
2024
Q4
Sell
-5,085
Closed -$206K 180
2024
Q3
$206K Buy
+5,085
New +$191K 0.07% 172
2024
Q2
Sell
-5,366
Closed -$202K 177
2024
Q1
$202K Buy
+5,366
New +$192K 0.08% 164
2022
Q1
Sell
-4,906
Closed -$202K 123
2021
Q4
$202K Buy
+4,906
New +$185K 0.1% 116

Other funds holding EXC

Bill Few Associates's EXC Position: Q2 2026 in Review

Bill Few Associates increased its Exelon (EXC) stake by 0.3% in Q2 2026, buying an estimated $833 and bringing the position to 5,987 shares worth $279K. The position accounts for 0.06% of the portfolio, ranked #194.

Bill Few Associates first reported a position in EXC in Q4 2021 and has held it in 9 quarters since. The position peaked at $293K in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Bill Few Associates held 5,987 shares of Exelon worth $279K as of Q2 2026.
  • Bill Few Associates bought 18 Exelon shares in Q2 2026, an estimated $833.
  • Exelon made up 0.06% of Bill Few Associates's portfolio in Q2 2026, its #194 holding.
  • Bill Few Associates first reported a position in Exelon in Q4 2021 and has held it in 9 quarters since.
  • Bill Few Associates's Exelon position peaked at $293K in Q1 2026.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.